Federal health regulators have approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking such safeguards.
A New York couple who said Botox treatment of their son's cerebral palsy left him with life-...
U.S. officials acknowledged disagreements over coordinating the international response to the...
This stainless steel, sanitary bulk bag filler detects and separates metal as it fills bulk bags by weight, dust-free. The filler frame is a patented TWIN-CENTERPOST™ design that maximizes strength, reduces cost and improves accessibility to bag hooks.
The SaniSep™ Plus Separator is engineered for use in pharmaceutical, food, dairy and other cross-contaminant, sensitive applications. With a crevice-free interior and streamlined exterior, the SaniSep Plus is designed and manufactured to CGMP standards and meets the requirements of 3A, USDA, ASTM and FDA applications.
Roadside bandits in Guinea stole a cooler containing blood samples that are believed to have Ebola, officials said Friday, warning of the risks and vowing tighter security measures for transport of such potentially contagious cargo.
Peter Daszak, President of the EcoHealth Alliance, explains the origins of Ebola and how we can fight emerging diseases.
New research finds that the costs of diabetes care and lost productivity due to the condition totaled $322 billion in 2012. Also, new warnings about hookah smoke.
The CMDh, a regulatory body representing EU Member States, has agreed by consensus that there is no consistent evidence of an increased risk of heart problems with testosterone medicines in men who lack the hormone (a condition known as hypogonadism).
A German federal court has ruled that the liquids contained in e-cigarettes aren't medicinal products and can be sold freely.
Anthera Pharmaceuticals has signed a manufacturing and supply agreement with the Patheon division of DPx Holdings B.V. The contract provides for Patheon to support the production of the Sollpura clinical drug product for Anthera's Phase III registration trial.
The ECP Series Thermoplastic Quarter Turn Electric Actuators feature a GFPP (Glass Filled Polypropylene) housing that provides the actuator superior corrosion resistance and performance in environments and atmospheres where most metal actuators cannot.
The average cost of developing an approved therapy is around $4.3 billion dollars for companies with three or more approved therapies, according to an analysis completed by Forbes. Imagine, then, our surprise when we discovered a biotechnology company outside of New York City that had developed three approved therapies for an average cost of $0.7 billion dollars – less than 20 percent of the industry average.
The Cystic Fibrosis Foundation says it has sold royalty rights worth $3.3B for innovative drugs it helped develop with Vertex Pharmaceuticals. The drug rights were acquired by Royalty Pharma, which owns royalty rights to 40 pharmaceutical medicines.
Vetter has announced the opening of a new representative office in Singapore. The announcement was made at a ceremony attended by members of local government agencies and a number of executives of pharmaceutical/biotech companies with a presence in the Asian region, as well as Vetter executives.
Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington lawmakers.
Study finds significant amount of arsenic in rice products that could have an impact on the health of people who consume it.
A new report by the McKinsey Global Institute says that the global cost of obesity has risen to $2 trillion annually — nearly as much as smoking or the combined impact of armed violence, war and terrorism.